Hoki Roe Green-Lipped Mussel Synergistic Omega-3 Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing joint health supplements face challenges in consistently providing sufficient omega-3 fatty acids, particularly with green-lipped mussel powder, which often has unreliable and insufficient omega-3 content, making it difficult to maintain effective anti-inflammatory pathways for joint health in humans and animals.
Innovation Solution
A composition combining at least 5% hoki roe powder with green-lipped mussel powder, which synergistically increases the omega-3 fatty acid content to meet the required specifications, providing enhanced anti-inflammatory activity beyond the additive effect of individual components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If green-lipped mussel powder is used as the primary omega-3 source, then the composition can be simplified and manufacturing is easier, but the omega-3 content is unreliable and insufficient to meet technical specifications
Solution Approach 1:
The patent combines green-lipped mussel powder with hoki roe powder to create a blended composition. This merging of two marine powder sources resolves the contradiction by maintaining the ease of manufacture advantage while achieving reliable and sufficient omega-3 content through the complementary fatty acid profiles of both ingredients.
Solution Approach 2:
The invention creates a composite material system consisting of green-lipped mussel powder and hoki roe powder in specific ratios. This composite approach allows the composition to achieve both manufacturing simplicity and reliable omega-3 content by leveraging the properties of both constituent materials working together synergistically.
2Reliability
If high specification green-lipped mussel powder is used, then the omega-3 content is sufficient, but the availability is rare and harder to source
Solution Approach 1:
The patent segments the omega-3 sourcing strategy by using multiple marine powder components rather than relying on a single high-specification green-lipped mussel powder. This segmentation allows the composition to achieve sufficient omega-3 content through combination while improving market availability by accepting lower specification individual components that are more easily sourced.
Solution Approach 2:
Hoki roe powder acts as an intermediary component that bridges the gap between available lower-specification green-lipped mussel powder and the required omega-3 content. This intermediary ingredient enables the formulation to achieve target specifications without requiring rare high-specification single-source materials.
3Device complexity
If the composition uses only additive effects of individual omega-3 sources, then the formulation is straightforward, but the anti-inflammatory activity is insufficient for effective joint health support
Solution Approach 1:
The patent merges green-lipped mussel powder and hoki roe powder in a way that generates synergistic anti-inflammatory activity greater than the sum of individual components. This combining approach resolves the contradiction by achieving enhanced anti-inflammatory efficacy while maintaining relatively straightforward formulation through the use of two well-defined marine powder ingredients.
Solution Approach 2:
The invention creates a composite material system that exhibits synergistic biological activity. The composite of green-lipped mussel and hoki roe powders produces enhanced anti-inflammatory effects compared to individual components, resolving the contradiction between formulation simplicity and biological efficacy through the synergistic interaction of the composite ingredients.
Data Source
AI summary
The invention concerns novel compositions, comprises at least 2 different sources of ω-3 fatty acids, wherein the first is hoki roe powder at 5% (w/w) particularly for use in supplements and/or animal or human food stuffs. The invention may further relate to the treatment of veterinary conditions, such as use in the improvement of inflammation or joint related disorders that maybe associated with inflammation.